Related Experiment Video

Updated: Jun 25, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Pharmacologic treatment of pediatric bipolar disorder

Jayasree J Nandagopal1, Melissa P DelBello, Robert Kowatch

  • 1Department of Psychiatry, University of Cincinnati, College of Medicine, 260 Stetson Street, Cincinnati, OH 45267, USA. jayasree.nandagopal@uc.edu

Child and Adolescent Psychiatric Clinics of North America
|March 7, 2009
PubMed

Insights

Pediatric bipolar disorder (BPD) diagnosis is rising. Early pharmacologic treatment with mood stabilizers and antipsychotics can improve outcomes for children and adolescents with BPD, including those with ADHD.

Area of Science:

  • Child and Adolescent Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Bipolar disorder (BPD) is increasingly diagnosed in children and adolescents.
  • Understanding the phenomenology of pediatric BPD is crucial for early intervention.
  • Minimizing psychosocial disability and improving prognosis are key goals in treating pediatric BPD.

Purpose of the Study:

  • To review the literature on pharmacologic treatment strategies for pediatric bipolar disorder.
  • To discuss appropriate medication options for children and adolescents with BPD.
  • To address treatment complexities in comorbid BPD and attention deficit/hyperactivity disorder (ADHD).

Main Methods:

  • Literature review of pharmacologic treatments for pediatric BPD.
  • Analysis of data supporting the use of mood stabilizers and atypical antipsychotics in youth.
  • Examination of treatment considerations for comorbid conditions.

Main Results:

  • Traditional mood stabilizers and atypical antipsychotics are commonly used in pediatric BPD.
  • Emerging data support the efficacy of these agents in this population.
  • Specific challenges in treating comorbid BPD and ADHD are highlighted.

Conclusions:

  • Pharmacologic interventions are essential for managing pediatric bipolar disorder.
  • Appropriate medication selection and management can improve outcomes for youth with BPD.
  • Addressing comorbidities like ADHD is critical for comprehensive treatment planning.

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications